Stay up-to-date
Follow us on social media
Latest news
Grifols announces topline phase 3 data on long-term Albutein® (albumin [human] U.S.P.) therapy for decompensated cirrhosis with ascites
Grifols ranked number one biotech company in Dow Jones Sustainability Indices
Grifols concludes balance sheet improvement process with private placement of Senior Secured Notes and Revolving Credit Facility extension
Media contacts
Journalist or media professional?
Our media relations team can be reached at:
(+34) 93 571 00 02
media@grifols.com.
Restricted to media inquiries only.
Not a journalist?
For general questions and requests, please contact corporatecomms@grifols.com.
Press Releases
Stay up-to-date on corporate developments as well as innovations in our plasma-derived medicines and other products and solutions.
Company Statements
Our official position on important matters.